Profile data is unavailable for this security.
About the company
Shanghai Junshi Biosciences Co Ltd is a China-based company primarily engaged in the discovery, development and commercialisation of innovative drugs. The Company’s products primarily include TUOYI toripalimab, recombinant humanized anti-tumor anti-B-and T-lymphocyte attenuator (BTLA) monoclonal Tifcemalimab, MINDEWEI deuremidevir hydrobromide tablets, JUNMAIKANG adalimumab, JUNSHIDA ongericimab, programmed death-1 (PD-1) monoclonal antibody subcutaneous injection formulation and others. The products are primarily used to treat malignant tumors, autoimmune diseases, chronic metabolic diseases, neurologic diseases and infectious diseases. The Company primarily operates its businesses in the domestic and American markets.
- Revenue in HKD (TTM)2.64bn
- Net income in HKD-1.19bn
- Incorporated2012
- Employees2.67k
- LocationShanghai Junshi Biosciences Co Ltd16F, Building 7, No. 6, Lane 100Pingjiaqiao Road, Pudong New AreaSHANGHAI 201203ChinaCHN
- Phone+86 2 161058800
- Fax+86 2 161757377
- Websitehttps://www.junshipharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ab&B Bio Tech Co Ltd JS | 366.68m | -254.18m | 20.26bn | 583.00 | -- | 531.53 | -- | 55.26 | -0.646 | -0.646 | 0.932 | 0.0969 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.29bn | 1.78k | 5.56 | 2.11 | 5.41 | 4.31 | 4.18 | 4.18 | 5.39 | 11.02 | 0.3966 | 7.09 | 3.86 | 2,598,991.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Shanghai Henlius Biotech Inc | 6.57bn | 933.59m | 24.35bn | 3.54k | 40.95 | 9.91 | 17.24 | 3.71 | 1.72 | 1.72 | 12.08 | 7.10 | 0.5386 | 1.73 | 5.86 | 1,868,170.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.97bn | 3.47bn | 24.60bn | 17.40k | 6.53 | 1.29 | 5.90 | 1.54 | 1.91 | 1.91 | 8.79 | 9.70 | 0.5397 | 2.89 | 5.97 | 939,504.00 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| PegBio Co Ltd | -100.00bn | -100.00bn | 24.66bn | 58.00 | -- | 84.18 | -- | -- | -- | -- | -- | 0.749 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -448.45m | 24.99bn | 6.53k | -- | 56.46 | 20,892.96 | 6.54 | -0.7777 | -0.7777 | 6.63 | 0.7683 | -- | -- | -- | 583,523.60 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.83bn | 12.44k | 12.72 | 1.54 | 10.35 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.54bn | 3.20bn | 28.96bn | 86.00k | 9.06 | 0.5118 | 2.22 | 0.098 | 0.509 | 0.509 | 47.04 | 9.01 | 0.9434 | 5.57 | 2.41 | 4,065,209.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.46bn | -3.21bn | 30.29bn | 191.00 | -- | 8.97 | -- | 12.32 | -36.99 | -36.99 | 28.71 | 37.47 | -- | -- | -- | 14,459,600.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.19m | -630.13m | 32.73bn | 197.00 | -- | 34.17 | -- | 904.41 | -1.22 | -1.22 | 0.0699 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.05bn | 996.87m | 33.46bn | 6.82k | 31.81 | 3.89 | 23.97 | 4.16 | 0.4053 | 0.4053 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,222,488.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
| Shanghai Junshi Biosciences Co Ltd | 2.64bn | -1.19bn | 35.32bn | 2.67k | -- | 3.04 | -- | 13.38 | -1.21 | -1.21 | 2.68 | 7.05 | 0.2053 | 0.9692 | 4.77 | 1,023,919.00 | -10.22 | -17.57 | -13.47 | -22.00 | 76.90 | 68.42 | -49.75 | -84.49 | 1.41 | -336.25 | 0.3528 | -- | 29.67 | 20.24 | 43.79 | -- | -4.35 | -- |
| China Medical System Holdings Ltd | 8.90bn | 1.87bn | 36.91bn | 6.10k | 19.57 | 1.91 | 17.08 | 4.15 | 0.7732 | 0.7732 | 3.68 | 7.90 | 0.4239 | 3.14 | 6.12 | 1,449,608.00 | 8.85 | 16.35 | 9.88 | 18.70 | 71.47 | 75.03 | 20.88 | 32.20 | 5.28 | -- | 0.0417 | 40.16 | -6.79 | 4.22 | -32.54 | -3.75 | 6.01 | -2.60 |
Data as of Feb 13 2026. Currency figures normalised to Shanghai Junshi Biosciences Co Ltd's reporting currency: Hong Kong Dollar HKD
